Oftalmol Zh.2013;2;56-60

https://doi.org/10.31288/oftalmolzh201325660

Intravitreal ranibizumab injection in the treatment of cystoid diabetic macular edema

N. N. Umanets, Z. A. Rozanova, Maher Alzein

SI «Filatov Institute of Eye Diseases and Tissue Therapy of National Academy of Medical Sciences of Ukraine»

Key words: diabetic macular edema, ranibizumab, intravitreal injection.

The aim of the study was to investigate the efficacy of intravitreal injection of 0,5 mg ranibizumab in the treatment of cystoid diabetic macular edema as a monotherapy. In the study was included 41 eyes (type I of diabetes mellitus — 31 patient, type II of diabetes mellitus — 19 patients, blood glucose less than 13,0pMol/l) non-proliferative diabetic retinopathy (DR) — 78,0 %, preproliferative DR — 14,6 %, proliferative DR — 7,4 %. Macular thickness (MT) and foveal avascular zone (FAZ) in fluorescent angiography images and best corrected visual acuity (BCVA) were measured. During the year 1 bevacizumab injection to 7,3 %, 2 injections to 24,4 % and 3 injections to 68,3 % of patients were done. After the one year of the start of treatment MT significantly reduced from 506±20 pm to 376±21,9 pm, FAZ reduced from 1,1±0,24 mm2 do 0,9±0,24 mm2 and BCVA increased or stabilized in 63,4 % patients.

 
References
1.Махер Альзин. Прогноз положительного результата панмакулярной коагуляции «решетка» у больных с кистозным диабетическим макулярным отеком [Текст] / Махер Альзин, Н. Н. Уманец, 3. А. Розанова // Таврический медико-биологический вестник. — 2012. — том 15. — № 3. — С. 96- 99.
2.Науменко В. А. Эффективность нового метода диагностики и лазерного лечения отечных форм диабе-тической макулопатии // автореферат дисс канд мед наук. — Одесса, 2004 г.
3.Antcliff R. J. The pathogenesis of edema in diabetic maculopathy [Текст] / R. J. Antcliff, J. Marshall // Semin. Ophthalmol. — 1999. — № 14. — Р. 223- 232.
Crossref
4.Arevalo J. F. Primary intravitreal bevacizumab for diffuse diabetic macular edema [Текст] / J. F. Arevalo, J. G. Sanchez, L. Wu [et al.] // Ophthalmology. — 2009.— № 116.— P. 1488— 1497.
Crossref
5.Erol N. Vision, retinal thickness, and avascular zone size after intravitreal bevacizumab for diabetic macular edema [Текст] / N. Erol, H. Gursoy, S. Kimion [et al.] // Adv Ther. — 2012. — № 4. — P. 359— 369.
Crossref
6.Ferrara N. Vascular endothelial growth factor: basic science and clinical progress [Текст] / N. Ferrara // Endocr. Rev. — 2004. — № 25. — Р. 581-611.
Crossref
7.Gaudreault J. Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration [Текст] / J. Gaudreault, D. Fei, J. Rusit [et.al.] // I. O. V. S. — 2005.— Vol.6.— № 2.— P.726— 733.
Crossref
8.Jonas J. B. Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study [Текст] / J. B. Jonas, B. A. Kamppeter, B. Harder, [et al.] //J. Ocul. Pharmacol. Ther. — 2006. — № 22. — Р. 200-207.
9.Klein R. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema [Текст] / R. Klein, B. E. Klein, S. E. Moss [et al.] // Ophthalmol¬ogy. — 1984. — № 91. — Р.1464- 1474.
Crossref
10.Lee C. M. Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results [Текст] / C. M. Lee, R. J. Olk // Ophthalmology.—  1991. — № 98. — Р.1594- 1602.
Crossref
11.Mitchell P. The RESTORE Study Ranibizumab Mono¬therapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema [Текст] / P. Mitchell, F Bandello, U. Schmidt-Erfurth [et al.] // Ophthalmol¬ogy. — 2011. — № 118. — Р.615- 625.
12.Murakami T. Foveal cystoids spaces are associated with enlarged foveal avascular zone and microaneuysms in diabetic macular edema [Текст]/ T. Murakami, K. Nishi-jima, A. Sakamoto [et al.] // Ophthalmology.— 2011.— № 118.— P.359- 367.
Crossref
13.Nguyen Q. D. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema [Текст] / Q. D. Nguyen, S. Tatlipinar, S. M. Shah, [et al.] // Am. J. Ophthalmol. — 2006. — № 142. — Р.961-969.
Crossref
14.Nguyen Q. D. Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study [Текст] / Q. D. Nguyen, S. M. Shah, A. A. Khwaja, [et al.] // Ophthalmology. — 2010. — № 117. — Р.2146 -2151.
Crossref
15.Pendergast S. D. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid [Текст] / S. D. Pendergast, T. S. Hassan, G. A. Williams [et al] // Am. J. Ophthalmol. — 2000. — № 130. — Р.178- 186.
Crossref
16.Tolentino M. J. Pathologic features of vascular endothe-lial growth factor-induced retinopathy in the nonhuman primate [Текст] / M. J. Tolentino, D. S. McLeod, M. Tao-moto, [et al.] // Am. J. Ophthalmol.— 2002.— № 133. — Р.373-85.
Crossref
17.Zimmet P. Global and societal implications of the diabetes epidemic [Текст] / P. Zimmet, K. G. Alberti, J. Shaw // Nature. — 2001. — № 414. — Р. 782- 787.
Crossref